|
Group Post |
WHO releases strategy paper on COVID disease management and long-term disease prevention |
mike kraft |
|
Group Post |
WHO releases global COVID-19 vaccination strategy update to reach unprotected |
FNUOvviyaa |
|
Group Post |
WHO release on beginning of COVAX vaccine shipments |
mike kraft |
|
Group Post |
WHO reform needed in wake of pandemic, public health experts say |
mike kraft |
|
Group Post |
WHO recommends reduced dose Pfizer COVID vaccine for under 12s |
mike kraft |
|
Group Post |
WHO recommends antibody treatment for some COVID-19 patients |
mike kraft |
|
Group Post |
WHO recomends 2 monoclonal antibodies for severe COVID |
mike kraft |
|
Group Post |
WHO plans slew of COVID-19 vaccine approvals for global rollout - document |
mike kraft |
|
Group Post |
WHO panel to recommend 'deeper' study in China of early Covid-19 clues |
mike kraft |
|
Group Post |
WHO panel backs use of Omicron-adapted vaccine as booster dose |
FNUOvviyaa |
|
Group Post |
WHO official warns dengue fever, a painful disease. will become a major threat this decade |
mike kraft |
|
Group Post |
WHO official says Covid booster jabs ‘not a luxury’ and protect the vulnerable |
mike kraft |
|
Group Post |
WHO official opposes boosters before 1st vaccines reach poor countries |
mike kraft |
|
Group Post |
WHO new graphics on the world wide spread of COVID-19 |
mike kraft |
|
Group Post |
WHO needs reforms, while preserving 'political independence': panel |
mike kraft |
|
Group Post |
WHO Monkeypox Research - What study designs can be used to address the remaining knowledge gaps for monkeypox vaccines? |
FNUOvviyaa |
|
Group Post |
WHO member states agree to fix 'rotten' funding model |
mike kraft |
|
Group Post |
WHO Meeting warns Coronavirus pandemic will be with us for a long time |
mike kraft |
|
Group Post |
WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission... |
mike kraft |
|
Group Post |
WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use |
mike kraft |
|
Group Post |
WHO lays out plan to emerge from emergency phase of pandemic |
mike kraft |
|
Group Post |
WHO Issues New Clinical Advice on Treating COVID-19 Patients |
mike kraft |
|
Group Post |
WHO issues initial evaluation of new EG.5 COVID variant and recomendationss |
mike kraft |
|
Group Post |
WHO is waiting for full data on Merck antiviral pill |
mike kraft |
|
Group Post |
Who is dying of COVID amid omicron surge and widespread vaccine availability? |
mike kraft |
Recent Comments